Ftse Mib
34.400,99
0,00%
DAX
20.242,57
-0,05%
S&P 500
5.872,16
-2,95%
NASDAQ
19.392,69
-3,56%
Bitcoin
101.226,13
1,16%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Quince Therapeutics Inc (QNCX) Quince Therapeutics Inc (QNCX) Notizie

Quince Therapeutics Inc

QNCX
1,93
0,09 (4,89%)
19 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202422:03EDGAR2Form S-3 - Registration statement under Securities Act of..
14/11/202412:55EDGAR2Form 8-K - Current report
14/11/202403:17EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
13/11/202423:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202422:05BWQuince Therapeutics Provides Business Update and Reports..
12/11/202422:05BWQuince Therapeutics Presents Data from Prior Phase 3 ATTeST..
11/11/202422:05BWQuince Therapeutics Presents Safety Data from Prior Phase 3..
14/10/202422:05BWQuince Therapeutics to Participate at Upcoming Investor..
03/9/202422:05BWQuince Therapeutics to Present at H.C. Wainwright 26th..
22/8/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202413:00BWQuince Therapeutics Announces The Lancet Neurology..
13/8/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:10EDGAR2Form 8-K - Current report
13/8/202422:05BWQuince Therapeutics Provides Business Update and Reports..
25/6/202413:00BWQuince Therapeutics Announces First Patient Dosed in Phase 3..
08/6/202403:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202402:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202423:17EDGAR2Form 8-K - Current report
05/6/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202413:00BWQuince Therapeutics Receives U.S. FDA Fast Track Designation..
13/5/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202413:00BWQuince Therapeutics Provides Business Update and Reports..
06/5/202422:05BWQuince Therapeutics to Present at The Citizens JMP Life..
01/4/202413:00BWQuince Therapeutics Provides Business Update and Reports..
22/2/202413:00BWQuince Therapeutics Launches Scientific Advisory Board
15/2/202422:00EDGAR2Form 8-K - Current report
15/2/202413:00BWQuince Therapeutics Appoints Former Reata Pharmaceuticals..
07/2/202422:05BWQuince Therapeutics to Present at Oppenheimer 34th Annual..
02/2/202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:01EDGAR2Form 8-K/A - Current report: [Amend]
04/1/202422:05BWQuince Therapeutics to Participate at Investor Events in..
03/1/202422:02EDGAR2Form 8-K - Current report
22/12/202322:08EDGAR2Form 8-K - Current report
Apertura: 1,95 Min: 1,84 Max: 2,00
Chiusura: 1,84

La tua Cronologia

NASDAQ
QNCX
Quince Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network